Improved Prognostic Survival Models Using High Dimensional Gene Expression Data
Akshitkumar Mistry
Co-Author
UofL Health – Brown Cancer Center, University of Louisville, Louisville, KY
Howard Donninger
Co-Author
UofL Health – Brown Cancer Center, University of Louisville, Louisville, KY
Kavitha Yaddanapudi
Co-Author
UofL Health – Brown Cancer Center, University of Louisville, Louisville, KY
Mst Sharmin Akter Sumy
Co-Author
Department of Bioinformatics and Biostatistics, SPHIS, University of Louisville, Louisville, KY
Sunday, Aug 3: 5:20 PM - 5:35 PM
1404
Contributed Papers
Music City Center
Recent genetic, epigenetic, and transcriptomic analyses have stratified Medulloblastoma (MB) into four subgroups of Wingless Type (WNT), Sonic Hedgehog (SHH), and Group 3 and Group 4, with discrete patient profiles and prognoses. Using a dataset of over ten thousand gene expression profiles, this study explores which genes can improve prognostic accuracy for survival, while accounting for molecular stratification and known clinical covariates. This approach involves a Benjamini-Hochberg screening of all genes, adjustment for molecular stratification and clinical covariates, followed by several high-dimensional models to predict survival. A case study of 483 pediatric MB patients demonstrated improved prognostic performance, as assessed by the C-index, Brier Scores, and time dependent AUCs, when gene expression data were included. Simulation studies validated the method's performance, successfully excluding non-informative genes in null scenarios and reliably identifying influential genes in alternative scenarios. This approach provides a robust framework for enhancing survival prediction and uncovering biologically significant markers.
High-dimensional genomic data
Medulloblastoma molecular stratification
prognostic models
variable selection
survival analysis
Main Sponsor
Section on Statistics in Genomics and Genetics
You have unsaved changes.